Stock Scheduled Dividends Tuesday, November 22, 2016

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Stock Scheduled Dividends Tuesday, November 22, 2016 05:07:22 AM

"Sch. Ex Date" Symbol Company Name Security Type Venue Type Cash Amt. Stock Amt. Freq.
Nov 23, 2016 APEMY Aperam New York Registry Shs OTC Link Cash Dividend 0.26563
Nov 23, 2016 CADNF Cascades Inc. Ordinary Shares OTC Link Cash Dividend 0.04
Nov 23, 2016 CBKM Consumers Bancorp, Inc. Common Stock OTC Link Cash Dividend 0.12
Nov 23, 2016 DELTY "Delta Galil Industries Ltd." American Depository Receipts OTC Link Cash Dividend 0.09174
Nov 23, 2016 EVSBY EVS Broadcasting Equipment SA American Depository Receipts OTC Link Cash Dividend 0.10289
Nov 23, 2016 FHB First Hawaiian, Inc. Nasdaq Cash Dividend 0.2 0 Quarterly
Nov 23, 2016 FINN First National of Nebraska, Inc. Common Stock OTC Link Cash Dividend 25
Nov 23, 2016 FIZZ National Beverage Corp. Common Stock Nasdaq Cash Dividend 1.5 0
Nov 23, 2016 GCHOY Grupo Nutresa SA American Depository Receipts OTC Link Cash Dividend 0.0116
Nov 23, 2016 INITF Iunits Government "Exchange Traded Fund" Grey Market Cash Dividend 0.05321
Nov 23, 2016 ISARF Ishares Canadian Dex Universe Bond Index Fund Fund Grey Market Cash Dividend 0.07109
Nov 23, 2016 ISHAF Ishares Income Trust Sector Index Fd Fund Grey Market Cash Dividend 0.05
Nov 23, 2016 ITSXF iUnits S&P/TSX Capped Financials Index Fund "Exchange Traded Fund" Grey Market Cash Dividend 0.07921
Nov 23, 2016 IUSPF Iunits "Exchange Traded Fund" Grey Market Cash Dividend 0.06878
Nov 23, 2016 JMPLY Johnson Matthey plc American Depository Receipts OTC Link Cash Dividend 0.48627
Nov 23, 2016 LVMUY "LVMH Moet Hennessy Louis Vuitton" American Depository Receipts OTC Link Cash Dividend 0.21783
Nov 23, 2016 LVMUY "LVMH Moet Hennessy Louis Vuitton" American Depository Receipts OTC Link Cash Dividend 0.21783 0
Nov 23, 2016 MATW Matthews International Corp. Common Stock Nasdaq Cash Dividend 0.17 0 Quarterly
Nov 23, 2016 MBCN Middlefield Banc Corp. Common Stock Nasdaq Cash Dividend 0.27 0 Quarterly
Nov 23, 2016 MKSI MKS Instruments, Inc. Common Stock Nasdaq Cash Dividend 0.17 0 Quarterly
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading